Similarly, an analysis of an insurance database in a Korean population reported no increased risk of HHF in DPP-4 inhibitor users (sitagliptin, linagliptin, vildagliptin and saxagliptin) when compared with SU [27]
Fatigue, reported in 8% to 12% of participants, is worth noting because its source matters
In healthy people who lose weight gradually (through diet and/or exercise), about 25% of the weight loss is LBM and 75% is fat
Muscle support: may support androgen receptor activity (how testosterone is used in muscle)
2025 Montana HB783 and Montana SB417 BillTrack50
Collectively, these data position GLP-1RAs as promising agents for the management of respiratory diseases, offering both symptomatic relief and potential disease-modifying effects